A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Gurka, Matthew J ^a   Ice, Christa L ^a   Sun, Shumei S ^b   DeBoer, Mark D ^c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adolescents; Clinical studies; Epidemiology; Factor analysis, Statistical; Insulin resistance; Metabolic syndrome; Obesity; Pediatrics; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHILD; ETHNIC GROUP; ETHNICITY; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE;

ADOLESCENT; AFRICAN AMERICANS; AGE FACTORS; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHILD; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR ANALYSIS, STATISTICAL; HISPANIC AMERICANS; HUMANS; INSULIN; METABOLIC SYNDROME X; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEX FACTORS; TRIGLYCERIDES; UNITED STATES; URIC ACID; YOUNG ADULT;

EID: 84867322164     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-128     Document Type: Article

References (49)

1. Shen BJ, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A, Ward KD. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003, 157(8):701-711. 10.1093/aje/kwg045, 12697574.
2. Tenenbaum A, Fisman EZ. " The metabolic syndrome. is dead" : these reports are an exaggeration. Cardiovasc Diabetol 2011, 10(1):11. 10.1186/1475-2840-10-11, 3036609, 21269524.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112(17):2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
4. Lawlor DA, Ebrahim S, May M, Davey Smith G. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 2004, 159(11):1013-1018. 10.1093/aje/kwh150, 15155285.
5. Li C, Ford ES. Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care 2007, 30(6):1556-1561. 10.2337/dc06-2481, 17363752.
6. Martinez-Vizcaino V, Martinez MS, Aguilar FS, Martinez SS, Gutierrez RF, Lopez MS, Martinez PM, Rodriguez-Artalejo F. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care 2010, 33(6):1370-1372. 10.2337/dc09-2049, 2875456, 20299487.
7. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007, 115(19):2526-2532. 10.1161/CIRCULATIONAHA.106.657627, 17470699.
8. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 2008, 152(2):201-206. 10.1016/j.jpeds.2007.09.010, 18206689.
9. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. The metabolic syndrome in children and adolescents. Lancet 2007, 369(9579):2059-2061. 10.1016/S0140-6736(07)60958-1, 17586288.
10. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005, 28(4):878-881. 10.2337/diacare.28.4.878, 15793189.
11. Gagliardi AC, Miname MH, Santos RD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 2009, 202(1):11-17. 10.1016/j.atherosclerosis.2008.05.022, 18585721.
12. Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012, 41(3):450-457. 10.1007/s12020-012-9629-8, 22350659.
13. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000, 151(2):190-198. 10.1093/oxfordjournals.aje.a010187, 10645822.
14. DeBoer MD, Dong L, Gurka MJ. Racial/Ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents. J Pediatr 2011, 159(6):975-981. e973, 10.1016/j.jpeds.2011.05.023, 21784441.
15. Sung KC, Seo MH, Rhee EJ, Wilson AM. Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol 2011, 10:108. 10.1186/1475-2840-10-108, 3275515, 22129309.
16. Martinez-Vizcaino V, Ortega FB, Solera-Martinez M, Ruiz JR, Labayen I, Eensoo D, Harro J, Loit HM, Veidebaum T, Sjostrom M. Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovasc Diabetol 2011, 10:81. 10.1186/1475-2840-10-81, 3193025, 21933439.
17. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation 2005, 112(5):666-673. 10.1161/CIRCULATIONAHA.104.516948, 16061755.
18. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB, Wagenknecht LE, Haffner SM. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the insulin resistance atherosclerosis study. Circulation 2005, 112(24):3713-3721. 10.1161/CIRCULATIONAHA.105.559633, 16344402.
19. van Vliet M, Heymans MW, von Rosenstiel IA, Brandjes DP, Beijnen JH, Diamant M. Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol 2011, 10:106. 10.1186/1475-2840-10-106, 3258193, 22114790.
20. DeBoer MD. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition 2012,
21. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third national health and nutrition examination survey. Circulation 2004, 110(16):2494-2497. 10.1161/01.CIR.0000145117.40114.C7, 15477412.
22. DeBoer MD, Gurka MJ. Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006. Metab Syndr Relat Disord 2010, 8(4):343-353. 10.1089/met.2010.0008, 3046372,3046372, 20698802.
23. Lee S, Bacha F, Gungor N, Arslanian S. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr 2008, 152(2):177-184. 10.1016/j.jpeds.2007.07.053, 18206686.
24. Reinehr T, de Sousa G, Toschke AM, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child 2007, 92(12):1067-1072. 10.1136/adc.2006.104588, 2066078, 17301109.
25. Sumner AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr 2009, 155(3):e7-11. S7, 3275909, 19732569.
26. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med 2003, 163(4):427-436. 10.1001/archinte.163.4.427, 3146257, 12588201.
27. Walker SE, Gurka MJ, Oliver MN, Johns DW, Deboer MD. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis 2012, 22(2):141-148. 10.1016/j.numecd.2010.05.006, 20708390.
28. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005, 111(10):1233-1241. 10.1161/01.CIR.0000158136.76824.04, 15769763.
29. DeBoer MD, Gurka MJ, Sumner AE. Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in Non-Hispanic black adolescents: an analysis of NHANES 1999-2008. Diabetes Care 2011, 34(3):734-740. 10.2337/dc10-1877, 3041218, 21285387.
30. DeBoer MD, Gurka MJ. Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: An analysis of NHANES 1999-2006. Atherosclerosis 2012, 220(2):575-580. 10.1016/j.atherosclerosis.2011.11.033, 22178428.
31. DeBoer MD. Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab 2011, 6(2):279-289. 10.1586/eem.11.17, 3105461, 21643518.
32. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008, 196(2):696-703. 10.1016/j.atherosclerosis.2006.12.018, 17254586.
33. Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 2008, 7:17. 10.1186/1475-2840-7-17, 2430947, 18534019.
34. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care 2005, 28(9):2289-2304. 10.2337/diacare.28.9.2289, 16123508.
35. Hong TK, Trang NH, Dibley MJ. Prevalence of metabolic syndrome and factor analysis of cardiovascular risk clustering among adolescents in Ho Chi minh city, Vietnam. Prev Med 2012, E-pub ahead of print.
36. Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58(4):773-795. 10.2337/db09-9028, 2661582, 19336687.
37. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120(16):1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
38. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation 2004, 109(3):433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958.
39. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004, 350(23):2362-2374. 10.1056/NEJMoa031049, 15175438.
40. CDC A SAS program for the CDC growth charts http://www.cdc.gov.com, accessed 6/7/12, CDC.
41. Bosy-Westphal A, Booke CA, Blocker T, Kossel E, Goele K, Later W, Hitze B, Heller M, Gluer CC, Muller MJ. Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr 2010, 140(5):954-961. 10.3945/jn.109.118737, 20335625.
42. Freedman DS, Sherry B. The validity of BMI as an indicator of body fatness and risk among children. Pediatrics 2009, 124(Suppl 1):S23-34.
43. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000, 85(2):251-255. 10.1016/S0002-9149(99)00635-9, 10955386.
44. Yaun KH, Bentler PM. On Chi-square difference and Z-tests in mean and covariance structure analysis when the base model is misspecified. Educ Psychol Meas 2004, 64:737-757.
45. Hu LT, Bentler PM. Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria vs. new alternatives. Struct Equ Model 1999, 6:1-55.
46. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter?. Circulation 2007, 115(13):1806-1810. discussion 1811, 10.1161/CIRCULATIONAHA.106.658336, 17404171.
47. Standards of medical care in diabetes. Diabetes Care 2012, 35(Suppl 1):S11-63.
48. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7(8):941-946. 10.1038/90984, 11479627.
49. Davidson MH. Apolipoprotein measurements: is more widespread use clinically indicated?. Clin Cardiol 2009, 32(9):482-486. 10.1002/clc.20559, 19743499.